- Home
- ZVRA vs NRC Comparison
ZVRA vs NRC Comparison
Compare ZVRA & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- NRC
- Stock Information
- Founded
- ZVRA 2006
- NRC 1981
- Country
- ZVRA United States
- NRC United States
- Employees
- ZVRA N/A
- NRC N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ZVRA Health Care
- NRC Health Care
- Exchange
- ZVRA Nasdaq
- NRC Nasdaq
- Market Cap
- ZVRA 511.6M
- NRC 426.3M
- IPO Year
- ZVRA 2015
- NRC N/A
- Fundamental
- Price
- ZVRA $8.49
- NRC $17.17
- Analyst Decision
- ZVRA Strong Buy
- NRC
- Analyst Count
- ZVRA 7
- NRC 0
- Target Price
- ZVRA $21.20
- NRC N/A
- AVG Volume (30 Days)
- ZVRA 550.1K
- NRC 114.1K
- Earning Date
- ZVRA 11-12-2024
- NRC 02-11-2025
- Dividend Yield
- ZVRA N/A
- NRC 2.80%
- EPS Growth
- ZVRA N/A
- NRC N/A
- EPS
- ZVRA N/A
- NRC 1.12
- Revenue
- ZVRA $24,489,000.00
- NRC $144,155,000.00
- Revenue This Year
- ZVRA N/A
- NRC N/A
- Revenue Next Year
- ZVRA $383.29
- NRC N/A
- P/E Ratio
- ZVRA N/A
- NRC $15.29
- Revenue Growth
- ZVRA 47.85
- NRC N/A
- 52 Week Low
- ZVRA $4.20
- NRC $16.74
- 52 Week High
- ZVRA $9.76
- NRC $42.18
- Technical
- Relative Strength Index (RSI)
- ZVRA 44.11
- NRC 35.82
- Support Level
- ZVRA $8.17
- NRC $16.74
- Resistance Level
- ZVRA $8.73
- NRC $18.31
- Average True Range (ATR)
- ZVRA 0.41
- NRC 0.80
- MACD
- ZVRA -0.10
- NRC -0.22
- Stochastic Oscillator
- ZVRA 21.77
- NRC 13.46
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.